Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.
Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call.
Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago.
The chemicals industry—companies creating chemicals used in industrial, commercial, and a variety of other applications—thrived for many years leading up to and including the COVID-19 pandemic. However, a recent report by McKinsey & Co. shows that the period since the end of the pandemic has brought a sharp reversal of this trend, with chemicals companies as a group achieving growth of under 2% per year since late 2022 while global indexes have increased 24% per year over the same period.
Here is how Blachem (BCPC) and Fresnillo PLC (FNLPF) have performed compared to their sector so far this year.
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here is how Blachem (BCPC) and MAG Silver (MAG) have performed compared to their sector so far this year.
Blachem (BCPC) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here is how Blachem (BCPC) and L.B. Foster (FSTR) have performed compared to their sector so far this year.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.